Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Method Development for Particle Size Analysis – V 2.0

Posted on By

Analytical Method Development: Method Development for Particle Size Analysis – V 2.0

Standard Operating Procedure for Method Development for Particle Size Analysis in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/115/2025
Supersedes SOP/AMD/115/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the method development procedure for determining particle size distribution (PSD) of active pharmaceutical ingredients (APIs), excipients, and drug products using

laser diffraction and other appropriate techniques in Analytical Method Development (AMD).

2. Scope

This procedure applies to all particle size analysis method development, optimization, and preliminary validation studies conducted within the AMD department for pharmaceutical solids and suspensions.

3. Responsibilities

  • Analytical Scientist: Designs and executes method development experiments, interprets PSD data, and maintains logs.
  • Instrument Operator: Performs equipment calibration, sample loading, and ensures measurement accuracy.
  • QA Officer: Verifies documentation, calibration records, and procedural adherence.
  • Head – AMD: Approves final method protocol and ensures regulatory compliance.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all particle size analysis methods are scientifically justified, adequately documented, and aligned with regulatory requirements.

See also  Analytical Method Development: SOP for Solution Stability Studies - V 2.0

5. Procedure

5.1 Instrument Selection

  1. Select appropriate technique based on material type and size range:
    • Laser Diffraction (0.1 – 3000 µm)
    • Dynamic Light Scattering (10 nm – 10 µm)
    • Optical Microscopy (≥ 1 µm)
    • Sieve Analysis (≥ 38 µm)
  2. Record instrument details and software version in Annexure-1: Instrument Selection Log.

5.2 Sample Preparation

  1. Weigh ~20–50 mg of sample for dry analysis or disperse in ~10–20 mL of diluent (for wet method).
  2. Use sonication or surfactants (e.g., 0.1% Tween 80) if necessary to prevent agglomeration.
  3. Filter large particles or foreign matter if required without affecting PSD.
  4. Document preparation steps in Annexure-2: Sample Preparation Log.

5.3 Dispersion Medium Selection

  1. Select a dispersion medium based on:
    • Chemical compatibility
    • Refractive index difference
    • Low viscosity and volatility
  2. Common media: Water, Isopropanol, Acetone (with appropriate safety precautions).
  3. Log medium selection in Annexure-3: Dispersion Medium Assessment.

5.4 Method Development and Optimization

  1. Define measurement parameters:
    • Obscuration (10–20% for laser diffraction)
    • Pump/stirring speed (as per equipment guidelines)
    • Refractive index (of sample and dispersant)
  2. Conduct replicate trials (n=3–5) to assess method precision and reproducibility.
  3. Evaluate PSD results for:
    • D10, D50, and D90 values
    • Span = (D90 – D10) / D50
    • Distribution pattern (mono-modal, bi-modal)
  4. Document in Annexure-4: Optimization and Result Summary.
See also  Analytical Method Development: SOP for Assay Method for Multicomponent Tablet - V 2.0

5.5 Method Robustness and Preliminary Validation

  1. Alter variables such as sonication time, dispersion media, or stirring rate to assess method sensitivity.
  2. Check for stability of dispersion over time (e.g., PSD consistency after 5, 10, 30 minutes).
  3. Perform day-to-day variability studies using same and different analysts.
  4. Log all robustness findings in Annexure-5: Robustness and Validation Sheet.

5.6 Safety Precautions

  1. Wear appropriate PPE when handling solvents or volatile materials.
  2. Ensure proper waste disposal of dispersants in accordance with MSDS and environmental regulations.
  3. Document safety checks in Annexure-6: Safety Compliance Log.

6. Abbreviations

  • PSD: Particle Size Distribution
  • DLS: Dynamic Light Scattering
  • D50: Median Particle Diameter
  • PPE: Personal Protective Equipment
  • SOP: Standard Operating Procedure

7. Documents

  1. Instrument Selection Log – Annexure-1
  2. Sample Preparation Log – Annexure-2
  3. Dispersion Medium Assessment – Annexure-3
  4. Optimization and Result Summary – Annexure-4
  5. Robustness and Validation Sheet – Annexure-5
  6. Safety Compliance Log – Annexure-6

8. References

  • USP <429> – Particle Size Analysis
  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • Instrument manufacturer’s method development guide

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Selection Log

Instrument Type Make Model Software Selected For
Laser Diffraction Malvern Mastersizer 3000 v3.80 API-B

Annexure-2: Sample Preparation Log

Sample ID Weight Medium Sonication Time Prepared By
PSD-115-A 25 mg Water + 0.1% Tween 80 5 min Sunita Reddy

Annexure-3: Dispersion Medium Assessment

Water was chosen over isopropanol due to better dispersibility, lower viscosity, and absence of peak distortion.

Annexure-4: Optimization and Result Summary

D10 (µm) D50 (µm) D90 (µm) Span Distribution Type
2.3 6.8 15.5 1.94 Mono-modal

Annexure-5: Robustness and Validation Sheet

Parameter Changed Condition D50 (µm) RSD (%)
Sonication Time 3 vs 5 min 6.8 / 6.7 1.5

Annexure-6: Safety Compliance Log

Date Solvent Used PPE Worn Disposal Method Verified By
18/05/2025 IPA Gloves, goggles Hazardous waste bin Rajesh Kumar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded to include robustness and safety annexures Annual Update
See also  Analytical Method Development: Data Integrity in Method Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Backup and Archiving of Analytical Data – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Reconciliation of Materials Used in Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version